A phase II trial of PXS-4728A in patients with non-alcoholic steatohepatitis
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2017
At a glance
- Drugs BI 1467335 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 06 Sep 2017 Status changed from planning to recruiting, according to a Pharmaxis media release.
- 23 May 2017 New trial record
- 15 May 2017 This trial is expected to begin in mid-2017, according to a Pharmaxis media release.